Please use this identifier to cite or link to this item:
Title: In vivo sensitization to gliadin by oral administration
Author: Romero Romero, María del Mar
Serra i Cucurull, Dolors
Castellanos-Rubio, Ainara
Herrero Rodríguez, Laura
Keywords: Malaltia celíaca
Celiac disease
Issue Date: 2022
Publisher: Elsevier
Abstract: Celiac disease is a highly prevalent immune-mediated enteropathy that develops in genetically susceptible individuals expressing HLA-DQ2 or HLA-DQ8 after ingestion of gluten and results in decreased quality of life and increased morbidity. This pathology is triggered by immunogenic peptides generated from gliadins present in gluten, which act on the intestinal mucosa in a context of high intestinal permeability, activating the innate and adaptive response of the immune system. Several in vivo rodent models attempt to reproduce some phases of the intestinal inflammatory process that occurs in celiac disease. Allergic sensitization to gluten simulates, or enhances in some animal models, the loss of tolerance to gliadin peptides and the initial events that lead to celiac disease in a specific genetic or environmental context. Here we describe a simple method for performing gliadin sensitization in an in vivo animal model.
Note: null
It is part of: Methods in Cell Biology, 2022
ISSN: 0091-679X
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)

Files in This Item:
File Description SizeFormat 
727401.pdf322.12 kBAdobe PDFView/Open    Request a copy

Embargat   Document embargat fins el 31-12-2099

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.